肝素诱导性血小板减少症相关研究进展
发布时间：2018-11-01 18:54
【摘要】：肝素诱导性血小板减少症(HIT)是一种少见的危急性、免疫性普通肝素或低分子肝素引起的并发症。HIT在接受肝素治疗患者中的发病率为0.6%~5%,尤其是对心血管手术或介入治疗患者危害很大,是目前临床研究热点。本文就HIT发病机制、流行病学、临床评估和治疗等方面研究进展作一简要综述。
[Abstract]:Heparin-induced thrombocytopenia (HIT) is a rare and critical complication caused by immune heparin or low-molecular-weight heparin. The incidence of HIT in patients receiving heparin therapy is 0.6%. Especially for cardiovascular surgery or interventional therapy patients are very harmful, is the current focus of clinical research. This article reviews the pathogenesis, epidemiology, clinical evaluation and treatment of HIT.
【作者单位】： 上海交通大学附属第六人民医院放射介入科;解放军第85医院放射科;
【分类号】：R558.2
本文编号：2304800
[Abstract]:Heparin-induced thrombocytopenia (HIT) is a rare and critical complication caused by immune heparin or low-molecular-weight heparin. The incidence of HIT in patients receiving heparin therapy is 0.6%. Especially for cardiovascular surgery or interventional therapy patients are very harmful, is the current focus of clinical research. This article reviews the pathogenesis, epidemiology, clinical evaluation and treatment of HIT.
【作者单位】： 上海交通大学附属第六人民医院放射介入科;解放军第85医院放射科;
【分类号】：R558.2
【相似文献】
相关期刊论文 前2条
1 陈兴峰;丁绍平;何明;徐安访;;起搏器介导性心律失常的临床影响因素分析[J];心血管病防治知识(学术版);2014年05期
2 ;[J];;年期
，本文编号：2304800
本文链接：https://www.wllwen.com/yixuelunwen/xxg/2304800.html
最近更新
教材专著
